Athersys Inc. (ATHX) Fundamentals

Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.
SHARE INFORMATION
Market Cap$ 71,235,721
Shares Outstanding263,933,756
Float246,851,546
Percent Float93.53%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 5,514,000
Latest Fiscal EPS$ -0.39
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions247
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months2,040,145
Institutional Holdings Percent27.8%
Institutional Sold Previous 3 Months23,227,427
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months83,333
Insider Holdings Percent1.7
Insider Sold Previous 3 Months25,448
Insider Shares Owned4,513,032
TRADING INFO
52 Week High$ 1.81
52 Week Low$ 0.17
52 Week High Change$ -82.47
21 Day Moving Average$ 0.2289
21 Day Extended Moving Average$ 0.245225
50 Day Moving Average$ 0.2568
50 Day Extended Moving Average$ 0.295515
200 Day Moving Average$ 0.707479
200 Day Extended Moving Average$ 0.683856
10 Day Average Volume41,593,749
20 Day Average Volume21,909,974
30 Day Average Volume16,884,801
50 Day Average Volume13,636,747
Alpha0.005554
Beta-1.2646
Standard Deviation0.246492
R20.065840
7 Day Price Change$ 0.0208
7 Day Percent Change8.35%
21 Day Price Change$ 0.0659
21 Day Percent Change32.3%
30 Day Price Change$ 0.0279
30 Day Percent Change11.53%
Month to Date Price Change$ 0.0208
Month to Date Percent Change8.35%
Quarter to Date Price Change$ 0.0099
Quarter to Date Percent Change3.81%
180 Day Price Change$ -0.6738
180 Day Percent Change-71.4%
200 Day Price Change$ -0.6066
200 Day Percent Change-69.21%
Year to Date Price Change$ -0.6327
Year to Date Percent Change-70.1%

Athersys Inc. (ATHX) Key Ratios

PROFITABILITY
EBIT Margin-983.2%
EBITDA Margin-966.3%
Pre-Tax Profit Margin-2,110.4%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 8,426,000
Revenue Per Share$ 0.0319
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book232.00
Total Debt To Equity31.00
Int Coverage0.00
Current Ratio1.00
Leverage Ratio6.40
Quick Ratio0.90
Long Term Debt To Capital0.97
VALUATION MEASURES
PE Ratio-0.80
Enterprise Value$ 58,957,720
Price to Sales8.4543
Price to Free Cash-1.20
PE High Last 5 Years-7.20
Price To Book232.00
Price To Cash Flow0.00
PE Low Last 5 Years-6.40
Price to Tangible Book232.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.50
Invoice Turnover0.00
Assets Turnover0.20
Return Assets-146.07
Return on Equity-449.07
Return on Capital-285.06

Athersys Inc. (ATHX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEODaniel A. Camardo
Emplyoees104
Last AuditUE
CIK0001368148
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address3201 Carnegie Avenue
Cleveland, OH 44115-2634
Websitehttps://www.athersys.com
Facsimile+1 216 361-9495
Telephone+1 216 431-9900
Emailir@athersys.com


Your Recent History
NASDAQ
ATHX
Athersys
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.